logo logo
  • Laboratory services
    • Request a presentation
    • Prostate cancer diagnosis
  • About us
    • Words from our CEO
    • Executive team
  • Careers
  • News & events
    • Inify Laboratories news
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Investor relations & media
logo logo
  • Start
  • Laboratory services
    • Inify laboratory services
    • Request a presentation
    • Prostate cancer diagnosis
  • About us
    • About us
    • Words from our CEO
    • Executive team
  • Newsroom
    • News & events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Investor relations & media

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2022-08-19
Stockholm, Sweden, August 19, 2022 – Inify Laboratories AB (“Inify”) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: Monsun AS, a Norwegian company controlled by Magne Jordanger, board member and primary insider in Inify, has bought 336,950 shares in Inify at an average […]
Read More
© Inify® Laboratories